KANK2 expression is significantly correlated with the infiltration levels of immune cells such as CD8+ T cells and macrophages in melanoma and NSCLC, which are crucial for the response to immunotherapy36, 37. Here, KANK2 is linked to non-small cell lung carcinoma.